An astonishing new trial suggests that Ozempic may help users not only drop pounds but also turn back time. In the first trial to directly measure the impact of semaglutide on aging, half of the ...

Scientists have found new evidence that Ozempic can help reverse aging — yet another health benefit added to the laundry list ...

FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and ...

Eli Lilly’s orforglipron cut body weight to a lesser extent than rival Novo Nordisk’s semaglutide, falling into analysts’ ...

In July 2025 alone, Wegovy clocked Rs 7 crore in sales with around 5,000 injections, while Mounjaro posted Rs 47 crore in ...

Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will ...

People with obesity who took Eli Lilly's daily oral GLP-1 drug orforglipron lost an average of 12.4% of their body weight, ...

It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very ...

OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second quarter of 2025 and recent weeks include ...

Several new weight loss drugs are undergoing trials in the UK. These drugs will work similarly to those already available but ...

The GLP-1 medication program by MedVi is now available nationwide starting at $179. NEWARK, DE - MedVi Wellness, a leading tele ...